EUROPEAN BIOTECHNOLOGY NETWORK
0521.742.313 · rovalta.com · 25/09/2026
EUROPEAN BIOTECHNOLOGY NETWORK
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOEUROPEAN BIOTECHNOLOGY NETWORK is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0521.742.313
- Legal form
- International non-profit organization
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 1,6 k € | +36.9% | 1,1 k € | -88.4% | 9,8 k € | – | 1,5 k € | ||
| EBITDA | -19,5 k € | -147% | 41,4 k € | +279% | -23,2 k € | -296% | -5,8 k € | -246% | 4 k € |
| Operating result | -19,5 k € | -147% | 41,4 k € | +279% | -23,2 k € | -296% | -5,8 k € | -246% | 4 k € |
| Net result | -19,6 k € | -148% | 40,6 k € | +274% | -23,3 k € | -288% | -6 k € | -257% | 3,8 k € |
| Balance sheet | |||||||||
| Equity | 5,4 k € | -78.4% | 25 k € | +260% | -15,6 k € | -302% | 7,7 k € | -43.8% | 13,7 k € |
| Total assets | 8,4 k € | -66.8% | 25,3 k € | -55.1% | 56,4 k € | -8.3% | 61,5 k € | -6.6% | 65,9 k € |
| Cash | 4,5 k € | -79.8% | 22,3 k € | -51.3% | 45,7 k € | +2.4% | 44,6 k € | -29.6% | 63,4 k € |
| Debts | 3 k € | +724% | 367,2 € | -99.5% | 72 k € | +33.9% | 53,8 k € | +3.1% | 52,2 k € |
Board of directors
Source · NBB, accounts to 31/12/20243 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/04/2025 | 22/05/2024 | 05/06/2023 | 25/05/2022 | 07/05/2021 |
| General meeting | 28/04/2025 | 16/05/2024 | 19/05/2023 | 20/05/2022 | 03/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20243 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution25/07/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Registered office31/12/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL
- Registered office07/10/2015SIEGE SOCIAL
- Other02/04/2014STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Other14/03/2013RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-19,6 k €↓
- 2023Annual accounts 202340,6 k €↑
- 2022Annual accounts 2022-23,3 k €↓
- 2021Annual accounts 2021-6 k €↓
- 2020Annual accounts 20203,8 k €